KevinMKorenblatMD

Gastroenterology • Saint Louis, MO

Advanced Endoscopic Interventional, Hepatology & Liver Transplantation

Associate Professor, Internal Medicine, Washington University School of Medicine

Join to view full profile

Dr. Korenblat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Korenblat's full profile

Already have an account?

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 314-747-2066

Fax+1 314-747-7111

Education & Training

Icahn School of Medicine at Mount SinaiPost-Doctoral Fellowship, Transplant Hepatology, 2002 - 2003
Massachusetts General HospitalFellowship, Gastroenterology, 1999 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1996 - 1999
Washington University in St. Louis School of MedicineClass of 1996

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 1997 - 2025
MA State Medical License 2001 - 2004
NY State Medical License 2002 - 2004
American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Start of enrollment: 2005 Aug 12
Terminated
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin Start of enrollment: 2010 Oct 11
Completed
Phase 3
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma Start of enrollment: 2009 Dec 16
Completed
Phase 1
Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis Start of enrollment: 2014 Sep 18
Completed
Phase 2
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Terminated
Phase 3
Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 Start of enrollment: 2016 Jul 13
Completed
Phase 3
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Start of enrollment: 2017 Aug 30
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

441 citations
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects
Kevin M. Korenblat, Elisa Fabbrini, B. Selma Mohammed, Samuel Klein
Gastroenterology. 2008-05-01
196 citations
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
Thomas D. Boyer, Arun J. Sanyal, Florence Wong, R. Todd Frederick, John R. Lake
Gastroenterology. 2016-06-01
630 citations
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis
Gastroenterology. 2015-09-01

Press Mentions

Subgroup Analysis CONFIRMs Telipressin Potential for Treating HRS, Alcoholic HepatitisMay 31st, 2023